X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
atheroembolism (212) 212
humans (124) 124
science & technology (116) 116
life sciences & biomedicine (111) 111
male (82) 82
aged (67) 67
risk factors (62) 62
middle aged (61) 61
female (60) 60
abridged index medicus (55) 55
research (47) 47
cardiovascular system & cardiology (44) 44
general & internal medicine (40) 40
care and treatment (37) 37
medicine, general & internal (36) 36
cardiac & cardiovascular systems (34) 34
atherosclerosis (33) 33
diagnosis (31) 31
cholesterol (27) 27
health aspects (25) 25
stroke (25) 25
causes of (23) 23
complications (22) 22
complications and side effects (20) 20
embolism, cholesterol - complications (19) 19
peripheral vascular disease (19) 19
physiological aspects (19) 19
embolism, cholesterol - diagnosis (18) 18
cardiovascular disease (16) 16
embolism - etiology (16) 16
prevention (16) 16
aged, 80 and over (15) 15
biopsy (15) 15
cardiovascular diseases (15) 15
case studies (15) 15
embolism, cholesterol - etiology (14) 14
prospective studies (14) 14
acute renal failure (13) 13
adult (13) 13
analysis (13) 13
dosage and administration (13) 13
drug therapy (13) 13
hypertension (13) 13
usage (13) 13
animals (11) 11
arteriosclerosis - complications (11) 11
development and progression (11) 11
patient outcomes (11) 11
angiography (10) 10
atherosclerosis - complications (10) 10
blood platelets (10) 10
diagnosis, differential (10) 10
embolism, cholesterol - therapy (10) 10
kidneys (10) 10
stents (10) 10
aorta (9) 9
aortic diseases - complications (9) 9
aspirin (9) 9
blue toe syndrome (9) 9
cardiology (9) 9
coronary heart disease (9) 9
embolism, cholesterol - pathology (9) 9
follow-up studies (9) 9
prognosis (9) 9
retrospective studies (9) 9
surgery (9) 9
coronary artery bypass (8) 8
diabetes (8) 8
embolism (8) 8
fatal outcome (8) 8
heart attacks (8) 8
incidence (8) 8
platelet aggregation inhibitors - therapeutic use (8) 8
cardiovascular diseases - prevention & control (7) 7
coronary vessels (7) 7
embolism, cholesterol - physiopathology (7) 7
lipids (7) 7
medicine (7) 7
stroke - etiology (7) 7
veins & arteries (7) 7
aggregation (6) 6
aorta, thoracic (6) 6
aspirin - therapeutic use (6) 6
atherosclerosis - therapy (6) 6
cholesterol embolism (6) 6
demographic aspects (6) 6
gene expression (6) 6
genetic aspects (6) 6
kidney - pathology (6) 6
medical imaging (6) 6
medicine & public health (6) 6
myocardial infarction - drug therapy (6) 6
patients (6) 6
randomized controlled trials as topic (6) 6
ticlopidine - analogs & derivatives (6) 6
transluminal angioplasty (6) 6
angioplasty (5) 5
angioplasty, balloon, coronary - adverse effects (5) 5
aortic diseases - diagnostic imaging (5) 5
aortic diseases - surgery (5) 5
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (210) 210
Spanish (7) 7
Japanese (4) 4
German (3) 3
French (1) 1
Italian (1) 1
Korean (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 04/2012, Volume 366, Issue 15, pp. 1404 - 1413
Patients with atherosclerotic vascular disease were randomly assigned to receive the thrombin antagonist vorapaxar or placebo. Vorapaxar reduced the rate of... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Risk | Secondary Prevention | Pyridines - adverse effects | Cardiovascular Diseases - mortality | Female | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Pyridines - therapeutic use | Double-Blind Method | Hemorrhage - epidemiology | Receptor, PAR-1 - antagonists & inhibitors | Kaplan-Meier Estimate | Peripheral Arterial Disease - drug therapy | Stroke - drug therapy | Lactones - adverse effects | Lactones - therapeutic use | Retreatment | Myocardial Infarction - drug therapy | Brain Ischemia - drug therapy | Intracranial Hemorrhages - chemically induced | Intracranial Hemorrhages - epidemiology | Aged | Hemorrhage - chemically induced | Prevention | Drugs | Aggregation | Dose-response relationship (Biochemistry) | Atheroembolism | Blood platelets | Atherosclerosis | Product/Service Evaluations | Dosage and administration | Drug therapy | Myocardial infarction | Cerebral infarction | Stroke | Aspirin | Heart attacks | Proteinase-activated receptor 1 | Thrombin | Hemorrhage | Patients | Bleeding | Disease prevention | Ischemia | Arteriosclerosis | Death | Cardiovascular diseases | Health risk assessment | Index Medicus | Abridged Index Medicus | Computer Science | Medical Imaging
Journal Article
The New England journal of medicine, ISSN 1533-4406, 04/2006, Volume 354, Issue 16, pp. 1706 - 1717
Journal Article
Journal Article
The Journal of clinical investigation, ISSN 0021-9738, 11/2012, Volume 122, Issue 12, pp. 4727 - 4731
Journal Article
Circulation (New York, N.Y.), ISSN 0009-7322, 09/2016, Volume 134, Issue 11, pp. 780 - 792
Journal Article
Archives of Cardiovascular Diseases Supplements, ISSN 1878-6480, 01/2019, Volume 11, Issue 1, pp. 5 - 6
Guidelines recommend risk stratification tools for use in acute myocardial infarction (AMI) to assist decisions making. Few tools are, however, available to... 
Journal Article